FINAL REPORT FOR ROUND TWO GRANTS #1
Effects of hyperbaric oxygen and aminoguanidine treatment on femoral head osteonecrosis in a rat model
Grant Agency: AH+DMRT
Total support: $10,000
Chief InvestigatorProfessor Ross Crawford, MBBS (QLD) 1987, FRACS 1997, DPhil (Oxon) 2000
Chair in Orthopaedic Research IHBI, QUT
Orthopaedic consultant at The Price Charles Hospital
Address: Kelvin Grove, Q Block - IHBI Level 7, 703G T
Telephone: +61 7 3139 4481 Fax: 3139 4043 Email: firstname.lastname@example.org
Other investigators:• Professor Yin Xiao, PhD, (UQ), 2000, MDSc (Wuhan) 1991, BDSc (Wuhan)
1986 Leader, Bone Biology group, IHBI, QUT
Address: Q Block – IHBI level 7, Institute of Health and Biomedical
Innovation, Queensland University of Technology, Kelvin Grove, Qld 4059
Telephone: 073138 6240 Fax: 3138 6030 Email: email@example.com
• Dr Ali Kalhor Mogahddam, MD (shaheed Beheshti medical University),
Master of research student (Queensland university of technology)
Orthopaedic registrar, The Prince Charles hospital
Address: The Prince Charles hospital, Rode Rd, Chermside, QLD, 4032
Telephone: 0731395168 Fax: 0731394250 Email: firstname.lastname@example.org
• Professor Dietmar Hutmacher, PhD (Natl Univ Singapore), MBA (Henley)
Chair in Regenerative MedicineIHBI, QUT
Address: 60 Musk Avenue, Kelvin Grove QLD 4059
Telephone: 3138 6077 Fax: 073138 6030 Email: email@example.com
• Dr Travis Klein, PhD (University of California – San Diego, USA 2005)
Postdoctoral Research Fellow, IHBI, QUT
Address: 60 Musk Ave, Kelvin Grove, Qld 4059, Australia
Telephone: 3138 6142 Fax: 3138 6030 Email: firstname.lastname@example.org
AIMS OF THE PROJECT1. Hyperbaric oxygen (HBO) and/or Aminoguanidine (AMG) reduce osteonecrosis
in idiopathic osteonecrosis of rat femoral heads.
2. HBO and AMG will act to reduce osteonecrosis by reducing osteoblast
apoptosis and expression of inducible nitric oxide synthase (iNOS)
Specific Aims:1. To determine if HBO and/or AMG prevent idiopathic osteonecrosis in a rat
2. To elicit mechanisms of HBO and AMG action in osteonecrosis by investigating
a. osteocyte apoptosis in an established model of osteonecrosis
b. expression of eNOS and iNOS in an established model of osteonecrosis
PROGRESS AND RESULTSApoptosis is the final destiny of many cells in the body, though this process has been
observed in some pathological processes. One of these pathological processes is
femoral head non-traumatic osteonecrosis. Among many pro/anti-apoptotic factors
nitric oxide has been recently an area of further interest. The osteocyte apoptosis and
its relation to proapoptotic action of inducible form of nitric oxide synthase (NOS)
which produce high concentration of nitric oxide have been flagged. The aim of this
study was to investigate the effect of hyperbaric oxygen (HBO) and inducible NOS
suppressor (Aminoguanidine) in prevention of femoral head osteonecrosis in a
experimental model of osteonecrosis, spontaneous hypertensive rats (SHRs).
After animal ethic approval 34 SHR rats were divided into four groups. Ten rats were
allocated to control group (who did not received any treatment), and eight rats
allocated to three treatment groups namely: HBO, Aminoguanidine (AMG), and the
combination HBO and AMG treatments (HBO+AMG). The HBO group received 250
kPa of oxygen through hyperbaric chamber for 30 days started at their 5th weeks of
life, the AMG group received 1mg/ml of AMG in drinking water from 5th weeks till
17th weeks of life, and the last group received combination of these treatments. Rats
were sacrificed at the end of 17th weeks of life and both femurs were analysed for
evidence of osteonecrosis using Micro CT scan, and H&E staining. Also, osteocyte
apoptosis and presence of two different forms of NOS (inducible (iNOS) and
endothelial (eNOS)) were analysed by immunostaining and apoptosis staining
(Hoechst and TUNEL).
Bone morphology of metaphyseal and epiphyseal area of all rats were investigated
and analysed. Micro CT findings revealed significantly higher mean fractional
trabecular bone volume (FBV) of metaphyseal area in untreated SHRs compared with
all other treatments (HBO, P<0.05, HBO+AMG, P<0.005, and AMG P<0.001). Bone
surface to volume ratio also significantly increased with HBO+AMG and AMG
treatments when compared with control group (18.7 Vs 20.8, P<0.05, and 18.7 Vs
21.1, P<0.05). Epiphyseal mean FBV did not change significantly among groups.
In metaphyseal area trabecular thickness and numbers significantly decreased with
AMG treatment, while trabecular separation significantly increased with both AMG
and HBO+AMG treatment.
Histological ratio of no ossification and osteonecrosis was 37.5%, 43.7%, 18.7% and
6.2% of control, HBO, HBO+AMG and AMG groups respectively with only
significant difference observed between HBO and AMG treatment (P<0.01).
High concentration of iNOS was observed in the region of osteonecrosis while there
was no evidence of eNOS activity around that region.
In comparison with control group, ratio of osteocyte apoptosis significantly reduced in
AMG treatment (P<0.005). We also observed significantly fewer apoptotic osteocytes
in AMG group comparing with HBO treatment (P<0.05).
CONCLUSIONNone of our treatments prevents osteonecrosis at histological or micro CT scan level.
High concentration of iNOS and significant reduction of osteocyte apoptosis with
AMG treatment were supportive of iNOS modulating osteocyte apoptosis in SHRs.
Budget:A total of $10,000 has been used for animal experiments, micro-CT,
immunohistochemistry, and histology.
A research paper will be submitted and the AHDMRT foundation will be informed
1 August 2013
ADDITIONAL REPORTS AND DETAILS